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often challenged despite recent literature that advocates a more
sympathetic assessment. Integral to this debate is the question of
whether VAS-based methods generate cardinal scales necessary
for economic evaluation. This study reports on that issue.
METHODS: A UK postal survey was used to elicit values for all
243 health states deﬁned by EQ-5D. A factorial block design was
used to construct 21 questionnaire versions in which a sample of
14 EQ-5D health states were valued by each respondent. Data
were obtained from 825 participants. Health states were ranked
in terms of their VAS scores on a within-respondent basis and
analysed using a conditional logit model to obtain estimated
values on an interval scale. The estimated values were compared
with directly observed VAS values rescaled so that the best state
(11111) was 100 and the worst state (33333) was 0. RESULTS:
The estimated values derived from this analysis were as much as
10 points higher than the rescaled, directly observed VAS scores.
Some differences in the rank order of health states were seen in
the two sets of values. However, a generally linear pattern was
seen between the computed and observed VAS values with a
Pearson correlation coefﬁcient as 0.969. OLS regression con-
ﬁrmed this relationship between estimated and observed VAS
values with the estimated value = VAS value*1.079 + 5.527.
CONCLUSION: Convergence between the two sets of values
conﬁrms the interval scale properties of the VAS value set, con-
ﬁrming the necessary cardinal measurement property to be legiti-
mately used in economic evaluation.
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OBJECTIVES: Generic Quality-of-life (QoL) instruments allow
to compare QoL in populations different for culture, languages,
health. If utilities are derivable, QoL data can be used in eco-
nomic research. Unfortunately children often remain excluded
from being part of these populations, hence information for
optimal decision-making in pediatric context can be limited. The
Child-Task-Force operating within the EuroQoL group is trans-
lating and validating a EQ-5D child version. Within the Child-
Task-Force, the Italian team conducted a validation study
involving 8–15 years old children in Italy. METHODS: Children
from general population were enrolled at schools, those with
chronic diseases enrolled at hospitals. Participants self-completed
a core-set containing: EQ-5D(child), open-questions on reasons
why they reported “no”, “some”, “a lot of” problems with each
EQ-5D-domain, standard measures for comparisons like
PEDsQL, a scale to self-rate global health, the World-Health-
Organization health scale, questions on demographic, socio-
economic, health status. After 10 days some kids underwent to a
re-test interview. Convergent and Discriminant validities were
tested by computing correlation coefﬁcients between every
couple of items/scores, as appropriate; concurrent validity was
tested by comparing the EQ-5D(child) responses of chronically
sick versus general population children; reliability was tested by
calculating agreement levels of test with re-test responses.
RESULTS: In total, 415 valid children from schools (31.1% were
re-tested), 11 Acute Linfoblastic Leukaemia patients form hospi-
tals were enrolled. Relevant Spearman’s correlation coefﬁcients
(>0.2, p < 0.0001) were found between every conceptually
similar items/scores; not signiﬁcant coefﬁcients were found
between most of not conceptually similar items. Weighted
Cohen’s Kappa were 0.2–0.5 in the proﬁle items. Intraclass-
Correlation-Coefﬁcient for VAS = 0.715. Leukaemia patients
more frequently reported problems/trouble in every EQ-5D item,
lower median (92.5 vs 98.0) and mean (83.0 vs 93.9) VAS.
CONCLUSION: EQ-5D(child) shows acceptable levels of valid-
ity and reliability. Further research will be conducted to improve
its properties and allow appropriate use in both research and
clinical practice.
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OBJECTIVES: SF-6D is an utility index, recently developed and
which has been validated for its use in Spanish population. It was
derived from SF-36 Health Survey, the most frequently used
generic HRQoL assessment instrument. Spanish general popula-
tion values for the SF-6D are presented here, along with some of
its characteristics and the comparison of two ways of using those
values. METHODS: The original database used to obtain the
General Population norms of the SF-36 in our country was used
in present analysis. This database includes the SF-36 data of
9151 non institutionalized subjects aged over 18, obtained in a
cross-sectional study of a random selected sample from GP.
SF-6D was calculated with and without the weights which rep-
resent the preferences of population about different health status.
The formula and the weights used were those used in the original
SF-6D version (Brazier et al). RESULTS: SF-6D score was higher
in males tan in females (F1.8975 = 177.467; p < 0.01). Statistically
signiﬁcant differences were observed in the SF-6D score among
different age groups (F6.8975 = 188.262; p < 0.01), lower scores
corresponding to elder age groups. There was a signiﬁcant inter-
action between both factors (F6.8975 = 5.456; p < 0.01). Variance
of SF-6D scores increases with the age. Direct SF-6D score
(without weights) and that obtained with weights of previous
preferences studies showed a high correlation (þ = 0.953;
p < 0.01; R2 = 0.91) CONCLUSION: Values calculated in
present analysis may be used as a reference for the SF-6D in
Spanish GP. They will allow a better interpretation of scores in
concrete groups of patients and in the individual patient (with
respect to age and gender). Results show that the use of weights
obtained in preference studies may not have the expected
relevance.
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OBJECTIVES: In current economic evaluation methods, ‘QALYs
gained’ is used as a summary outcome. The value of a patient
moving from a health state with utility 0.8 to full health (i.e. 1.0)
is considered equivalent to a change from 0.3 to 0.5, since both
show ‘improvements’ of 0.2. However, there is evidence to
suggest that the initial state may play an important role in the
patient’s own valuation of the health change. That is, the more
severe the initial state, the more a patient will value an ‘equal’
health gain. METHODS: Two experiments were developed,
using the visual analogue scale (VAS) and health utilities index
3 (HUI:3) methods of presenting health states. Participants
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